Aperam stock: JPMorgan cut target from EUR 57.00 to EUR 55.50 for Aperam stock

Published on 10/20/2026 at 15:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aperam reports Q3 results on November 6, 2026. Aperam stock costs EUR 37.06 on October 20, 2026, 31.18 percent below its high.

Analyst target and results

JPMorgan cut its Aperam target from EUR 57.00 to EUR 55.50 on October 15, 2026.
Aperam expects third-quarter adjusted EBITDA below EUR 130.00 million and above EUR 90.00 million, with EUR 113.00 million consensus.
Aperam stock costs EUR 37.06 at Lang & Schwarz on October 20, 2026 at 2:59 p.m. CEST, 31.18 percent below the 52-week high.
Aperam will publish third-quarter and nine-month results on November 6, 2026.

Aperam, LU0569974404, Illustration mit AI erstellt.

Aperam (ISIN LU0569974404) saw JPMorgan cut its price target from EUR 57.00 to EUR 55.50 on October 15, 2026, as reported by Markets Insider. Aperam stock was trading at EUR 37.06 at Lang & Schwarz on October 20, 2026 at 2:59 p.m. CEST.

JPMorgan target stays above price

The revised target remains EUR 18.44 above the Lang & Schwarz price. That equals 49.73 percent above the price, calculated from EUR 37.06 to EUR 55.50. JPMorgan retained an Overweight rating, according to the October 15 report.

Third-quarter earnings outlook

In its October 6, 2026 update, Aperam said third-quarter adjusted EBITDA, or earnings before interest, taxes, depreciation and amortization, should be below the EUR 130.00 million reported for the second quarter but above the EUR 90.00 million recorded in the first quarter. The company-compiled consensus stood at EUR 113.00 million, according to Webdisclosure.

Stock sits below yearly high

The stock's 52-week range was EUR 29.50 to EUR 53.85 on October 19, 2026, placing the Lang & Schwarz price 31.18 percent below the upper end. The same market snapshot listed a day range of EUR 37.30 to EUR 38.24 and a price-to-earnings ratio of 21.50, while Aperam's market capitalization was EUR 2.7 billion on October 20, 2026.

Dates and valuation

Investing.com identifies Aperam's primary listing as the Amsterdam Stock Exchange and gives the next earnings date as November 6, 2026. Aperam's third-quarter and nine-month results are scheduled before the market opens, followed by a conference call at 2:00 p.m. CET; the company's Capital Markets Day is scheduled for November 18, 2026, according to the October 6 release.

Price and investor perspective

The target reduction and the cautious third-quarter range leave the November results as the next concrete test for the earnings outlook. The price remains materially below its 52-week high, while the company's update also points to a EUR 150.00 million efficiency target for 2026 through 2028, with EUR 38.00 million delivered in the first half of 2026.

Aperam was trading at EUR 37.06 at Lang & Schwarz on October 20, 2026 at 2:59 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Aperam stock.